Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Journal of Molecular Biology|November 17, 2009
Molecular switch in the glucocorticoid receptor: active and passive antagonist conformationsGuillaume A Schoch, Brigitte D'Arcy, Martine Stihle, et al.FEBS Open Bio|June 18, 2013
Isothermal titration calorimetry with micelles: Thermodynamics of inhibitor binding to carnitine palmitoyltransferase 2 membrane proteinSamantha Perspicace, Arne C Rufer, Ralf Thoma, et al.Nature|November 5, 2004
Insight into steroid scaffold formation from the structure of human oxidosqualene cyclaseRalf Thoma, Tanja Schulz-Gasch, Brigitte D'Arcy, et al.Plos One|September 30, 2025
Exploring β-catenin and TCF4 interaction in complex environments by means of novel biosensing platform focal molographyPhilipp Cedro, Roman Popov, Maxime Karrer, et al.Acta Crystallographica. Section D, Biological Crystallography|January 20, 2011
Structural basis for the cyclophilin A binding affinity and immunosuppressive potency of E-ISA247 (voclosporin)Andreas Kuglstatter, Francis Mueller, Eric Kusznir, et al.Scientific Reports|March 25, 2018
MultiBacMam Bimolecular Fluorescence Complementation (BiFC) tool-kit identifies new small-molecule inhibitors of the CDK5-p25 protein-protein interaction (PPI)Itxaso Bellón-Echeverría, Jean-Philippe Carralot, Andrea Araujo Del Rosario, et al.Journal of Molecular Biology|September 21, 2010
Enhancing the stability and solubility of the glucocorticoid receptor ligand-binding domain by high-throughput library screeningTobias Seitz, Ralf Thoma, Guillaume A Schoch, et al.Biochemical and Biophysical Research Communications|January 2, 2013
Generation of an antibody toolbox to characterize hERGGeorg J Hausammann, Thomas Heitkamp, Hugues Matile, et al.Structure (London, England : 1993)|April 18, 2006
The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatmentArne C Rufer, Ralf Thoma, Jörg Benz, et al.Journal of Medicinal Chemistry|November 15, 2013
Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffoldsHans Hilpert, Harald Mauser, Roland Humm, et al.Pageof 3